Skaff Michael C's Form 4 filing
Vivos Therapeutics, Inc. (VVOS) · filed Jul 15, 2026
- Accession no.
- 0001193125-26-304815
- Filed
- Jul 15, 2026, 4:23 PM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 derivative transactions. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Skaff Michael CCIK 0002074003 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | PPurchaseAcquired | +859,166 | $0.582 | +$500,034.61 | 859,166 | Indirect | |
| Jun 30, 2026 | Common Stock | PPurchaseAcquired | +1,890,164 | $0.582 | +$1,100,075.45 | 2,749,330 | Indirect | |
| Jun 30, 2026 | Common Stock | PPurchaseAcquired | +2,749,330 | $0.582 | +$1,600,110.06 | 2,749,330 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.